56 pharmaceutical firms see stock assets go up

The aggregate market values of Korean drugmakers that went public on the local bourse rose by 2.3 percent this year, latest data showed.

According to Yakup.com, an online information provider on the nation’s drugmakers, Monday, the combined market value of the country’s 56 listed drug firms and seven preferred stocks reached 14.897 trillion won as of June 28, up 329 billion won from 14.568 t...